Is CRDL.TO undervalued or overvalued?

As of 2025-03-23, the Intrinsic Value of Cardiol Therapeutics Inc (CRDL.TO) is -2.19 CAD. This CRDL.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.63 CAD, the upside of Cardiol Therapeutics Inc is -227.90%. This means that CRDL.TO is overvalued by 227.90%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-2.19 - -2.19	-2.19	-227.90%
P/E	(3.15) - (4.46)	(3.83)	-323.8%
DDM - Stable	(4.21) - (35.94)	(20.08)	-1274.1%
DDM - Multi	(1.49) - (10.17)	(2.62)	-253.4%